Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Times Interest Earned (2022 - 2025)

Atara Biotherapeutics (ATRA) has disclosed Times Interest Earned for 4 consecutive years, with -$3.93 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Times Interest Earned rose 78.62% year-over-year to -$3.93, compared with a TTM value of $6.7 through Sep 2025, up 124.37%, and an annual FY2024 reading of -$18.08, up 65.38% over the prior year.
  • Times Interest Earned was -$3.93 for Q3 2025 at Atara Biotherapeutics, down from $3.29 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $38.15 in Q1 2025 and bottomed at -$22055.0 in Q1 2022.
  • Average Times Interest Earned over 4 years is -$1592.1, with a median of -$49.9 recorded in 2023.
  • The sharpest move saw Times Interest Earned soared 51.74% in 2024, then skyrocketed 240.78% in 2025.
  • Year by year, Times Interest Earned stood at -$645.63 in 2022, then surged by 92.1% to -$50.99 in 2023, then surged by 76.47% to -$12.0 in 2024, then surged by 67.23% to -$3.93 in 2025.
  • Business Quant data shows Times Interest Earned for ATRA at -$3.93 in Q3 2025, $3.29 in Q2 2025, and $38.15 in Q1 2025.